Pharmacological cyclin dependent kinase inhibitors: Implications for colorectal cancer
Volume: 22, Issue: 7, Pages: 2159 - 2164
Published: Feb 21, 2016
Abstract
Colorectal cancer accounts for a significant proportion of cancer deaths worldwide. The need to develop more chemotherapeutic agents to combat this disease is critical. Cyclin dependent kinases (CDKs), along with its binding partner cyclins, serve to control the growth of cells through the cell cycle. A new class of drugs, termed CDK inhibitors, has been studied in preclinical and now clinical trials. These inhibitors are believed to act as an...
Paper Details
Title
Pharmacological cyclin dependent kinase inhibitors: Implications for colorectal cancer
Published Date
Feb 21, 2016
Volume
22
Issue
7
Pages
2159 - 2164
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History